Bristol Myers Squibb’s path forward for research facility strategy and performance

Bristol Myers Squibb's research facility strategy has evolved to leverage the advantages of both leased and owned facilities while maintaining consistency in research endeavors, and here you’ll see how each model is contributing to adaptability and agility in the face of evolving industry dynamics. Paul Palmieri and Fred Mason relate their experience developing and implementing new decision-making criteria, facility investment priorities, and space use models. They deliver lessons learned from driving research facility portfolio performance, and creating an environment conducive to innovation, efficiency, and sustained success in the pharmaceutical landscape.